Patent: 10,172,850
✉ Email this page to a colleague
Summary for Patent: 10,172,850
| Title: | Substituted diketopiperazine analogs for use as drug delivery agents |
| Abstract: | Disclosed are drug delivery systems for the delivery of small molecule and macromolecular drugs. More particularly, disclosed are substituted analogs of 3,6-di(alkyl-4 aminobutyl)-2,5-diketopiperazine (which may also be referred to DKP), their use in the formulation of both small molecule and macromolecular drugs including therapeutic, prophylactic and diagnostic agents, stabilizing agents and systems for their delivery. |
| Inventor(s): | Kraft; Kelly Sullivan (Poughquag, NY) |
| Assignee: | MannKind Corporation (Westlake Village, CA) |
| Application Number: | 15/488,915 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,172,850
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 15-Jan-74 | ⤷ Start Trial | 2037-04-17 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 27-Dec-84 | ⤷ Start Trial | 2037-04-17 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 15-Feb-85 | ⤷ Start Trial | 2037-04-17 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 16-Feb-90 | ⤷ Start Trial | 2037-04-17 |
| Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | 26-Mar-74 | ⤷ Start Trial | 2037-04-17 |
| Fresenius Kabi Usa, Llc | CHORIONIC GONADOTROPIN | chorionic gonadotropin | For Injection | 017067 | 5-Mar-73 | ⤷ Start Trial | 2037-04-17 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
